<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03364660</url>
  </required_header>
  <id_info>
    <org_study_id>16.0179 TS EPI</org_study_id>
    <nct_id>NCT03364660</nct_id>
  </id_info>
  <brief_title>Task-specific Epidural Stimulation Study</brief_title>
  <acronym>TS EPI</acronym>
  <official_title>Task and Physiological Specific Stimulation for Recovery of Autonomic Function, Voluntary Movement, and Standing Using Epidural Stimulation and Training After Severe Spinal Cord Injury</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Louisville</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Louisville</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators propose to understand the role of lumbosacral spinal cord epidural&#xD;
      stimulation (scES) in recovery of autonomic nervous system function, voluntary movement, and&#xD;
      standing in individuals with severe spinal cord injury (SCI). Thirty-six individuals with&#xD;
      severe SCI who have cardiovascular and respiratory dysfunction and who are unable to&#xD;
      voluntarily move the legs or stand will receive scES for cardiovascular function, voluntary&#xD;
      movement, or standing with and/or without weight-bearing standing. Training will consist of&#xD;
      practicing voluntary movements or standing in the presence of specific scES configurations&#xD;
      designed for the voluntary movements of the legs and trunk (Vol-scES), or epidural&#xD;
      stimulation configurations specific for standing (Stand-scES). Specific configurations&#xD;
      epidural stimulation for cardiovascular function (CV-scES) will be provided during sitting&#xD;
      and supine and during maneuvers of orthostatic or cardiovascular stress. The ability to move&#xD;
      voluntarily, stand, as well as cardiovascular, respiratory, bladder, bowel and sexual&#xD;
      function will be assessed in these individuals with chronic severe spinal cord injury.&#xD;
      Quality of life and costs of health care also will be assessed.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Experimental Design&#xD;
&#xD;
      The investigators will enroll, implant and complete the interventions in 36 research&#xD;
      participants who have sustained a SCI in the proposed experiments. The investigators&#xD;
      anticipate they will need to screen 108 potential research participants to enroll 36&#xD;
      individuals who will complete the study. This sample size will provide sufficient replication&#xD;
      per study group (n=4) from which variance and effect size estimates for each study hypothesis&#xD;
      can be calculated, and hypothesis tests conducted. The investigators will also select&#xD;
      individuals to assure that there are a minimum of 25% (n=9) women to adequately represent the&#xD;
      percentage in the SCI population. The investigators will study each cohort of patients&#xD;
      comprehensively, and each individual will be allocated to the group interventions based on&#xD;
      the method of minimization. Research participants will be randomized into group&#xD;
      interventions. This novel approach of conducting repeated experiments with comprehensive&#xD;
      assessments in a smaller cohort of patients, rather than a more traditional approach of&#xD;
      including a large number of patients and focusing on a single outcome, will advance both&#xD;
      clinical and scientific knowledge in this highly complex population. The investigators have&#xD;
      found success with the smaller cohort approach because they can employ more rigorous,&#xD;
      quantitative and sensitive outcomes that not only inform them about the potential clinical&#xD;
      efficacy, but also provide further knowledge of the mechanisms of neural control of movement&#xD;
      and other physiological mechanisms related to cardiovascular, respiratory, bladder, bowel and&#xD;
      sexual function.&#xD;
&#xD;
      Group A:&#xD;
&#xD;
        -  Vol-scES during voluntary leg movement training while sitting or lying supine (A1).&#xD;
&#xD;
        -  CV-scES during sitting or lying supine (A2).&#xD;
&#xD;
      Group B:&#xD;
&#xD;
        -  Vol-scES during voluntary leg movement training + Stand-ES during stand training (B1).&#xD;
&#xD;
        -  CV-ES during sitting or lying supine + Stand-ES during stand training (B2).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 8, 2017</start_date>
  <completion_date type="Anticipated">June 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Recovery of autonomic control of cardiovascular function as assessed by cardiovascular assessments</measure>
    <time_frame>20 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Recovery of voluntary movement as assessed by functional movement assessments</measure>
    <time_frame>20 months</time_frame>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">36</enrollment>
  <condition>Spinal Cord Injuries</condition>
  <arm_group>
    <arm_group_label>Voluntary Movement Epidural Stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants assigned to this group will receive epidural stimulation specific for voluntary movement.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cardiovascular Epidural Stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants assigned to this group will receive epidural stimulation specific for cardiovascular function.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Voluntary Movement ES + Stand Training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants assigned to this group will receive epidural stimulation specific for voluntary movement and will also receive stand training.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cardiovascular ES + Stand Training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants assigned to this group will receive epidural stimulation specific for cardiovascular function and will also receive stand training.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Epidural Stimulation</intervention_name>
    <description>Eligible participants will be implanted with 16-electrode epidural array and epidural stimulator in the spinal cord.</description>
    <arm_group_label>Cardiovascular ES + Stand Training</arm_group_label>
    <arm_group_label>Cardiovascular Epidural Stimulation</arm_group_label>
    <arm_group_label>Voluntary Movement ES + Stand Training</arm_group_label>
    <arm_group_label>Voluntary Movement Epidural Stimulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Stand Training</intervention_name>
    <description>Standing in a body weight support (BWS) harness on a treadmill or standing in a standing frame.</description>
    <arm_group_label>Cardiovascular ES + Stand Training</arm_group_label>
    <arm_group_label>Voluntary Movement ES + Stand Training</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  At least 18 years of age&#xD;
&#xD;
          -  Non-progressive spinal cord injury&#xD;
&#xD;
          -  At least 2 years post injury&#xD;
&#xD;
          -  Stable medical condition&#xD;
&#xD;
          -  Unable to voluntarily move all individual joints of the legs&#xD;
&#xD;
          -  Unable to stand independently&#xD;
&#xD;
          -  Cardiovascular dysfunction including presence of persistent low blood pressures and/or&#xD;
             symptoms of autonomic dysreflexia and/or orthostatic hypotension and/or dysregulation&#xD;
             in response to postural changes and/or highly variable blood pressures in a 24 hour&#xD;
             period&#xD;
&#xD;
          -  Urodynamic dysfunction including dyssynergia and/or inability to void voluntarily&#xD;
             and/or low voiding capacity&#xD;
&#xD;
          -  Respiratory dysfunction including at least 15% deficit in predicted pulmonary function&#xD;
             outcomes&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Ventilator dependent&#xD;
&#xD;
          -  Untreated painful musculoskeletal dysfunction, fracture or pressure sore&#xD;
&#xD;
          -  Untreated psychiatric disorder or ongoing drug abuse&#xD;
&#xD;
          -  Cardiovascular, respiratory, bladder, or renal disease unrelated to spinal cord injury&#xD;
&#xD;
          -  Bladder botox injections less than 12 months prior to implant&#xD;
&#xD;
          -  Colostomy bag, urostomy&#xD;
&#xD;
          -  Any implanted pump (i.e., baclofen pump, pain pump, etc)&#xD;
&#xD;
          -  Ongoing nicotine use&#xD;
&#xD;
          -  Pregnant at the time of enrollment or planning to become pregnant during the time&#xD;
             course of the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Susan J Harkema, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Louisville</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Susan J Harkema, PhD</last_name>
    <phone>502-581-8675</phone>
    <email>susan.harkema@louisville.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Taylor A Blades, MS</last_name>
    <phone>502-582-7410</phone>
    <email>taylor.blades@louisville.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Louisville</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan Harkema, PhD</last_name>
      <phone>502-581-8675</phone>
      <email>taylor.blades@louisville.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>November 16, 2017</study_first_submitted>
  <study_first_submitted_qc>November 30, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 6, 2017</study_first_posted>
  <last_update_submitted>March 12, 2021</last_update_submitted>
  <last_update_submitted_qc>March 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Louisville</investigator_affiliation>
    <investigator_full_name>Susan Harkema</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Epidural Stimulation</keyword>
  <keyword>Spinal Cord Injury</keyword>
  <keyword>Task-Specific</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Cord Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>There is no plan to share individual participant data.</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>February 8, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/60/NCT03364660/Prot_002.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

